KALA BIO, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
KALA BIO, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2018 to Q3 2024.
  • KALA BIO, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$8.95M, a 2.83% decline year-over-year.
  • KALA BIO, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$39M, a 16.1% increase year-over-year.
  • KALA BIO, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$42.2M, a 5.85% increase from 2022.
  • KALA BIO, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$44.8M, a 68.6% increase from 2021.
  • KALA BIO, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$143M, a 36.7% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$39M -$8.95M -$246K -2.83% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$38.7M -$9.58M +$834K +8.01% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$39.6M -$11.8M +$2.65M +18.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$42.2M -$8.63M +$4.22M +32.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 -$46.4M -$8.7M -$37.8M -130% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$8.64M -$10.4M +$17.7M +63% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$26.3M -$14.5M +$18.5M +56.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$44.8M -$12.8M +$34.7M +73% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 -$79.5M $29.1M +$57.2M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$137M -$28.1M +$8.39M +23% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 -$145M -$32.9M -$2.53M -8.32% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$143M -$47.6M -$16.5M -52.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-03
Q3 2021 -$126M -$28.1M -$179K -0.64% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$126M -$36.5M -$13.2M -56.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$113M -$30.4M -$8.46M -38.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$104M -$31.1M -$9.15M -41.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 -$95.2M -$27.9M -$4.77M -20.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$90.4M -$23.3M +$513K +2.15% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$90.9M -$22M +$3.43M +13.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$94.3M -$22M +$3.26M +12.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$97.6M -$23.2M -$7.57M -48.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$90M -$23.8M -$9.21M -63% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$80.8M -$25.4M -$14.1M -125% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$66.7M -$25.2M Oct 1, 2018 Dec 31, 2018 10-K 2020-02-12
Q3 2018 -$15.6M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$14.6M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 -$11.3M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.